Scale -


  • Revenue is 828 Rs Cr; Annual Growth is 19 %; Continuous Growth over 3 years; 5 Year CAGR is 12 %
  • Ebitda is 306 Rs Cr; Continuous Growth over 3 years
  • PAT is 209 Rs Cr; Continuous Growth over 3 years; in Top Quartile

Profitability -


  • PBDIT Margin is 36.9 %; in Top Quartile
  • PAT Margin is 25.25 %; in Top Quartile

Return -


  • ROCE is 22.42 %; in Top Quartile
  • ROA is 15.4 %; in Top Quartile
  • ROE is 17.45 %; in Top Quartile

Efficiency -


  • Operating cash flow is 186 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 40 %
  • Current Ratio is 4.4; in Top Quartile
  • Quick Ratio is 3.08; in Top Quartile; Continuous Decline over 3 years
  • Inventory Turnover Ratio is 5.96; in Top Quartile; 5 Year CAGR is 25 %

Solvancy -


  • Debt/Equity is 0; in Bottom Quartile
  • Total Debt is 0 Rs Cr; in Bottom Quartile
  • Contingent Liabilities is 8.81 Rs Cr; Annual Growth is 111 %; Continuous Growth over 3 years

Quality -


  • Current Tax/PAT is 29 %; Continuous Decline over 3 years
  • Operating cashflow/ebitda is 61 %; 5 Year CAGR is 29 %; Continuous Decline over 3 years
  • Operating cashflow/PAT is 89 %; 5 Year CAGR is 29 %
  • Change in Inventories/Total Expenses is -2 %; Annual Growth is 58 %
  • Other Expenses/Total Expenses is 32 %; Continuous Growth over 3 years; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Supriya Lifescience Limited Estimates – NSE:SUPRIYA
Supriya Lifescience NSE:SUPRIYA Supreme Court Update
Supreme Court stays coercive action against Supriya Lifescience directors
Supriya Lifescience NSE:SUPRIYA Reg 74(5) Compliance Certificate Q2 FY27
Supriya Lifescience vs Nifty 50: 1Y Return +17.39% vs -10.93%
Supriya Lifescience (SUPRIYA.NS) Eases 1.21% to ?850.95, Holding Mid-Range Above ?808.4 Support
Supriya Lifescience files petition in Supreme Court over High Court order
Supriya Lifescience (SUPRIYA.NS) Slips 2.85% to ?889.25, Drifting Toward Key Support